|
Feb 21
|
3 US Growth Companies With Up To 28% Insider Ownership
|
|
Feb 21
|
Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?
|
|
Feb 20
|
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales
|
|
Feb 20
|
Q4 2024 Bausch + Lomb Corp Earnings Call
|
|
Feb 20
|
Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics
|
|
Feb 20
|
Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates
|
|
Feb 19
|
Bausch: Q4 Earnings Snapshot
|
|
Feb 19
|
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
|
|
Feb 19
|
Bausch + Lomb (BLCO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Feb 19
|
Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
|
|
Feb 19
|
Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates
|
|
Feb 19
|
Bausch + Lomb to shake up contact lenses with deal off the table
|
|
Feb 19
|
Bausch + Lomb Higher in U.S. Pre-market After Posting Increase in Q4 Adjusted Profit, Revenue
|
|
Feb 19
|
Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue
|
|
Feb 19
|
Bausch + Lomb: Q4 Earnings Snapshot
|
|
Feb 18
|
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect
|
|
Feb 17
|
What Analyst Projections for Key Metrics Reveal About Bausch (BHC) Q4 Earnings
|
|
Feb 17
|
Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key Metrics
|
|
Feb 16
|
Bausch Health Companies Inc. (NYSE:BHC) Could Be Less Than A Year Away From Profitability
|
|
Jan 18
|
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
|